Invesco Pharmaceuticals ETF PJP
130.54 USD +0.86 (+0.66%)
Nov 10, 2026, 3:58 PM EST
128.53 Day range 130.59
98.55 52-week range 132.59
- YTD
- +24.87%
- 1 year
- +32.66%
- Market cap
- 376.22M
- EPS (ttm)
- 5.85
- P/E ratio
- 22.32
- YTD return
- +24.87%
- 1-year return
- +32.66%
- Volume
- 10.21K
- Avg volume
- 35.29K
- Open
- 129.21
- Previous close
- 129.68
- Day's range
- 128.53 – 130.59
- 52-week range
- 98.55 – 132.59
No chart data for this range yet.
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 86.39
- 200-day average
- 83.44
About Invesco Pharmaceuticals ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
News
The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power? 
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? 
Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy? 
Papa Johns (PJP Investments Group) Puts People at the Centre of Growth with Blink Partnership 
Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP? 
Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens 
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP 
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? 
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks 
Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits
Your note
Sign in to keep a note on PJP — it syncs with the Stock Master app.